CRISPR Therapeutics AG (CRSP) EBT Margin Growth (5y) (2021 - 2026)
CRISPR Therapeutics AG (CRSP) EBT Margin Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -97,066.00 |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 5.04 Mn |
| Jun 30, 2025 | 15.69 Mn |
| Mar 31, 2025 | 2.86 Mn |
| Dec 31, 2024 | 98,941.00 |
| Sep 30, 2024 | -1.42 Mn |
| Jun 30, 2024 | -734,161.00 |
| Mar 31, 2024 | -825,686.00 |
| Dec 31, 2023 | 4.12 Mn |
| Jun 30, 2023 | 340,901.00 |
| Mar 31, 2023 | 202,587.00 |
| Dec 31, 2022 | -200.09 Mn |
| Sep 30, 2022 | -18.53 Mn |
| Jun 30, 2022 | -11.31 Mn |
| Mar 31, 2022 | -1.79 Mn |
| Dec 31, 2021 | -185,900.00 |
| Sep 30, 2021 | -1.46 Mn |
| Jun 30, 2021 | 224,375.00 |